We have seen 44 institutional investors add shares of $CCAP stock to their portfolio, and 44 decrease their positions in their most recent quarter.
Crescent Capital fundamentals remain robust with 107% dividend coverage, a conservative 40% portfolio LTV, and 2.2x interest coverage. See why CCAP stock is a buy.
Crescent Capital BDC, Inc. offers a 10.6% dividend yield and trades at an 11% discount to book value, making it a compelling income investment. CCAP's portfolio is conservatively managed with 90% ...
Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the five research firms that are presently covering the firm, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results